BLAUVELT, A. .; LACOUR, J.-P.; TOTH, D.; LAQUER, V.; BEISSERT, S.; WOLLENBERG, A.; HERRANZ, P.; PINK, A.; PERIS, K. .; FANGEL, S.; SAEKI, H. Long-Term Improvements Observed in Tralokinumab-Treated Patients with Moderate-to-Severe Atopic Dermatitis: an ECZTEND Interim Analysis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 5, n. 6, p. s59, 2021. DOI: 10.25251/skin.5.supp.59. Disponível em: Acesso em: 5 jul. 2022.